Long-term, frequent phone counseling helps cancer patients who smoke quit

October 13, 2020

BOSTON - Recently diagnosed cancer patients who smoke are significantly more likely to quit and remain tobacco-free if they receive frequent and sustained telephone counseling, according to a new study led by researchers at Massachusetts General Hospital (MGH). The study, published in JAMA, offers hope that these patients will respond better to treatment and enjoy improved quality of life while coping with cancer.

Studies suggest that between 10 percent and 30 percent of tobacco users who are diagnosed with cancer continue smoking. Moreover, half of those who stop relapse quickly. Cancer patients are not routinely referred to smoking-cessation programs, says psychologist Elyse R. Park, PhD, MPH, director of behavioral sciences at MGH's Tobacco Research and Treatment Center, and the lead author of the JAMA paper. Many clinicians may be reluctant to discuss the topic or may only recommend quitting to patients who have a smoking-related disease, such as lung cancer. However, explains Park, smoking can diminish the effectiveness of cancer treatment, as well as quality of life, for people with all forms of cancer.

"Cancer patients need help in order to achieve the best cancer treatment outcomes," says Park. Overall, fewer than 10 percent of smokers who attempt to quit succeed, according to the Centers for Disease Control and Prevention. Telephone counseling administered by certified tobacco treatment counselors has been shown to be an effective way to help smokers give up the habit, but most programs are relatively short term and focused on cancer prevention. Park and her team at MGH joined forces with psychologist Jamie S. Ostroff, PhD, and her colleagues at Memorial Sloan Kettering Cancer Center in New York City to investigate whether a sustained, more intensive program would improve quit rates among cancer patients.

The study included 303 patients with various forms of cancer. Half of the participants received phone calls from counselors four times a week for a month; during these sessions, counselors used evidence-based behavioral strategies designed to motivate the patient to continue abstaining from tobacco and cope with the stress of a cancer diagnosis. Patients also received advice about medications to aid smoking cessation, such as nicotine-replacement therapy. The intensive-treatment group received a similar schedule of telephone counseling, plus an additional four sessions every other week, for two months, and three monthly booster sessions. Patients in this group were also offered free smoking-cessation medications.

After six months, lab tests confirmed that 34.5 percent of the patients in the intensive-treatment program were abstaining from tobacco, compared to 21.5 percent of participants who received the shorter program with less frequent counseling. "We believe it was the ongoing, positive cessation support, in coordination with the oncology care these patients received, that led to the high success rate in the intensive-treatment group," says Park.

Park and her colleagues are now implementing this intensive tobacco treatment program at more than 40 community cancer centers around the United States. "This randomized trial demonstrated that tobacco treatment can and should be an integral part of comprehensive cancer care," says Park. "Cessation advice and support should start immediately, at the time of diagnosis, and it should be offered to all cancer patients, regardless of tumor type and stage of disease."
-end-
Elyse R. Park, PhD, MPH is a behavioral scientist at the MGH Mongan Institute, and also directs behavioral research at the MGH Cancer Survivorship Program and the MGH Benson-Henry Institute for Mind Body Medicine, and is an associate professor in the Departments of Psychiatry and Medicine at Harvard Medical School. The senior author of the JAMA study is Jamie S. Ostroff, PhD, a behavioral scientist at Memorial Sloan Kettering Cancer Center and professor of Psychology in the Departments of Psychiatry and Healthcare Policy and Research at the Weill Medical College of Cornell University.

About the Massachusetts General Hospital

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH Research Institute conducts the largest hospital-based research program in the nation, with an annual research budget of more than $1 billion and comprises more than 8,500 researchers working across more than 30 institutes, centers and departments. In August 2020 the MGH was named #6 in the nation by U.S. News & World Report in its list of "America's Best Hospitals."

Massachusetts General Hospital

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.